Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85.02 USD | -0.87% | +5.80% | +19.04% |
13/05 | Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing | MT |
08/05 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.04% | 154.07Cr | |
+32.36% | 71TCr | |
+30.77% | 60TCr | |
-1.60% | 37TCr | |
+20.07% | 33TCr | |
+6.04% | 29TCr | |
+14.77% | 24TCr | |
+9.13% | 21TCr | |
-3.97% | 20TCr | |
+9.27% | 17TCr |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Benchmark Adjusts Ligand Pharmaceuticals' Price Target to $130 From $180, Reiterates Buy Rating